Our study further demonstrated that peripheral blood CD39 mRNA could serve as a potential diagnostic marker for active TB, exhibiting superior accuracy compared to IFN-γ, especially when combined with TB-antigen-responsive genes like TBX21 and GZMB. The gene discussed is ENTPD1; the disease is tuberculosis.